FDA advisory panel reviews MDMA to treat PTSD

On June 4th the FDA Psychopharmalogic Drugs Advisory Committee met to review MDMA as a treatment for PTSD. Deran Young was a part of this important conversation and shared her own story as a way to advocate for its use.

Click here to listen to the entire meeting, or click here to begin listening to Deran’s insight.